Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone.

Frontiers in neurology

Ross AP, Ben-Zacharia A, Harris C, Smrtka J.
PMID: 23482896
Front Neurol. 2013 Mar 08;4:21. doi: 10.3389/fneur.2013.00021. eCollection 2013.

Relapses in multiple sclerosis (MS) are disruptive and frequently disabling for patients, and their treatment is often a challenge to clinicians. Despite progress in the understanding of the pathophysiology of MS and development of new treatments for long-term management...

Cite
Ross AP, Ben-Zacharia A, Harris C, et al. Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone. Front Neurol. 2013;4:21doi: 10.3389/fneur.2013.00021.
Ross, A. P., Ben-Zacharia, A., Harris, C., & Smrtka, J. (2013). Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone. Frontiers in neurology, 421. https://doi.org/10.3389/fneur.2013.00021
Ross, Amy Perrin, et al. "Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone." Frontiers in neurology vol. 4 (2013): 21. doi: https://doi.org/10.3389/fneur.2013.00021
Ross AP, Ben-Zacharia A, Harris C, Smrtka J. Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone. Front Neurol. 2013 Mar 08;4:21. doi: 10.3389/fneur.2013.00021. eCollection 2013. PMID: 23482896; PMCID: PMC3591751.
Copy Download .nbib Format: NLM
Melanocortin Regulation of Inflammation.

Frontiers in endocrinology

Wang W, Guo DY, Lin YJ, Tao YX.
PMID: 31649620
Front Endocrinol (Lausanne). 2019 Oct 09;10:683. doi: 10.3389/fendo.2019.00683. eCollection 2019.

Adrenocorticotropic hormone (ACTH), and α-, β-, and γ-melanocyte-stimulating hormones (α-, β-, γ-MSH), collectively known as melanocortins, together with their receptors (melanocortin receptors), are components of an ancient modulatory system. The clinical use of ACTH in the treatment of rheumatoid...

Cite
Wang W, Guo DY, Lin YJ, et al. Melanocortin Regulation of Inflammation. Front Endocrinol (Lausanne). 2019;10:683doi: 10.3389/fendo.2019.00683.
Wang, W., Guo, D. Y., Lin, Y. J., & Tao, Y. X. (2019). Melanocortin Regulation of Inflammation. Frontiers in endocrinology, 10683. https://doi.org/10.3389/fendo.2019.00683
Wang, Wei, et al. "Melanocortin Regulation of Inflammation." Frontiers in endocrinology vol. 10 (2019): 683. doi: https://doi.org/10.3389/fendo.2019.00683
Wang W, Guo DY, Lin YJ, Tao YX. Melanocortin Regulation of Inflammation. Front Endocrinol (Lausanne). 2019 Oct 09;10:683. doi: 10.3389/fendo.2019.00683. eCollection 2019. PMID: 31649620; PMCID: PMC6794349.
Copy Download .nbib Format: NLM
Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective.

Frontiers in endocrinology

Heyder N, Kleinau G, Szczepek M, Kwiatkowski D, Speck D, Soletto L, Cerdá-Reverter JM, Krude H, Kühnen P, Biebermann H, Scheerer P.
PMID: 31417496
Front Endocrinol (Lausanne). 2019 Jul 31;10:515. doi: 10.3389/fendo.2019.00515. eCollection 2019.

The melanocortin-4 receptor (MC4R) can be endogenously activated by binding of melanocyte-stimulating hormones (MSH), which mediates anorexigenic effects. In contrast, the agouti-related peptide (AgRP) acts as an endogenous inverse agonist and suppresses ligand-independent basal signaling activity (orexigenic effects). Binding...

Cite
Heyder N, Kleinau G, Szczepek M, et al. Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective. Front Endocrinol (Lausanne). 2019;10:515doi: 10.3389/fendo.2019.00515.
Heyder, N., Kleinau, G., Szczepek, M., Kwiatkowski, D., Speck, D., Soletto, L., Cerdá-Reverter, J. M., Krude, H., Kühnen, P., Biebermann, H., & Scheerer, P. (2019). Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective. Frontiers in endocrinology, 10515. https://doi.org/10.3389/fendo.2019.00515
Heyder, Nicolas, et al. "Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective." Frontiers in endocrinology vol. 10 (2019): 515. doi: https://doi.org/10.3389/fendo.2019.00515
Heyder N, Kleinau G, Szczepek M, Kwiatkowski D, Speck D, Soletto L, Cerdá-Reverter JM, Krude H, Kühnen P, Biebermann H, Scheerer P. Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective. Front Endocrinol (Lausanne). 2019 Jul 31;10:515. doi: 10.3389/fendo.2019.00515. eCollection 2019. PMID: 31417496; PMCID: PMC6685040.
Copy Download .nbib Format: NLM
Melanocortins and their implication in melanoma.

Trends in endocrinology and metabolism: TEM

Siegrist W, Eberle AN.
PMID: 18406692
Trends Endocrinol Metab. 1995 May-Jun;6(4):115-20. doi: 10.1016/1043-2760(95)00017-c.

The melanocortins (MCs), that is, the melanocyte-stimulating hormones (MSHs) and ACTH, are a group of related peptides containing the typical melanotropin core sequence, His-Phe-Arg-Trp, and are derived from a common precursor, pro-opiomelanocortin. They are pleiotropic molecules that occur in...

Cite
Siegrist W, Eberle AN. Melanocortins and their implication in melanoma. Trends Endocrinol Metab. 1995;6(4):115-20doi: 10.1016/1043-2760(95)00017-c.
Siegrist, W., & Eberle, A. N. (1995). Melanocortins and their implication in melanoma. Trends in endocrinology and metabolism: TEM, 6(4), 115-20. https://doi.org/10.1016/1043-2760(95)00017-c
Siegrist, W, and Eberle, A N. "Melanocortins and their implication in melanoma." Trends in endocrinology and metabolism: TEM vol. 6,4 (1995): 115-20. doi: https://doi.org/10.1016/1043-2760(95)00017-c
Siegrist W, Eberle AN. Melanocortins and their implication in melanoma. Trends Endocrinol Metab. 1995 May-Jun;6(4):115-20. doi: 10.1016/1043-2760(95)00017-c. PMID: 18406692.
Copy Download .nbib Format: NLM
The role of proopiomelanocortin (POMC) neurones in feeding behaviour.

Nutrition & metabolism

Millington GW.
PMID: 17764572
Nutr Metab (Lond). 2007 Sep 01;4:18. doi: 10.1186/1743-7075-4-18.

The precursor protein, proopiomelanocortin (POMC), produces many biologically active peptides via a series of enzymatic steps in a tissue-specific manner, yielding the melanocyte-stimulating hormones (MSHs), corticotrophin (ACTH) and beta-endorphin. The MSHs and ACTH bind to the extracellular G-protein coupled...

Cite
Millington GW. The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutr Metab (Lond). 2007;4:18doi: 10.1186/1743-7075-4-18.
Millington, G. W. (2007). The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutrition & metabolism, 418. https://doi.org/10.1186/1743-7075-4-18
Millington, George Wm. "The role of proopiomelanocortin (POMC) neurones in feeding behaviour." Nutrition & metabolism vol. 4 (2007): 18. doi: https://doi.org/10.1186/1743-7075-4-18
Millington GW. The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutr Metab (Lond). 2007 Sep 01;4:18. doi: 10.1186/1743-7075-4-18. PMID: 17764572; PMCID: PMC2018708.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries